Your browser doesn't support javascript.
loading
Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors.
Serrano, César; Leal, Alessandro; Kuang, Yanan; Morgan, Jeffrey A; Barysauskas, Constance M; Phallen, Jillian; Triplett, Olivia; Mariño-Enríquez, Adrián; Wagner, Andrew J; Demetri, George D; Velculescu, Victor E; Paweletz, Cloud P; Fletcher, Jonathan A; George, Suzanne.
Afiliación
  • Serrano C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. cserrano@vhio.net suzanne_george@dfci.harvard.edu.
  • Leal A; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.
  • Kuang Y; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology; Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Morgan JA; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Barysauskas CM; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Phallen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Triplett O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mariño-Enríquez A; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Wagner AJ; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Demetri GD; Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.
  • Velculescu VE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fletcher JA; Ludwig Center for Cancer Research at Dana-Farber Cancer Institute and Harvard Medical School, Boston Massachusetts.
  • George S; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Clin Cancer Res ; 25(24): 7287-7293, 2019 12 15.
Article en En | MEDLINE | ID: mdl-31471313
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Resistencia a Antineoplásicos / Tumores del Estroma Gastrointestinal / Neoplasias Gastrointestinales / Recurrencia Local de Neoplasia Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Resistencia a Antineoplásicos / Tumores del Estroma Gastrointestinal / Neoplasias Gastrointestinales / Recurrencia Local de Neoplasia Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article